With the advent of thrombolytic therapy and other coronary reperfusion strategies, rapid
identification and treatment of acute myocardial infarction greatly reduces mortality …

Physicians and other health care professionals play an important role in reducing the delay
to treatment in patients who have an evolving acute myocardial infarction. A multidisciplinary …

Objectives. This study sought to examine the relations among patient characteristics, time to
thrombolysis and outcomes in the international GUSTO-I trial. Background. Studies have …

The role of the intrinsic coagulation system on the risk of myocardial infarction is unclear. In
the Study of Myocardial Infarctions Leiden (SMILE) that included 560 men younger than age …

Background—A genetic variation located in the 3′-untranslated region of the prothrombin
gene (prothrombin 20210 G→ A) was recently described as a risk factor for venous …

Background: Stroke is a leading cause of death and disability in the United States. Although
new treatments are being studied, most must be given early in the course of stroke to be …

Background Greater use of thrombolysis for patients with myocardial infarction has been
limited by patient delay in seeking care for heart attack symptoms. Deficiencies in …

OBJECTIVE: To describe the older adult heart failure patients' symptoms and their duration
before a hospital admission and to explore related factors. DESIGN: The study was an …

Background The use of thrombolytic therapy for patients with myocardial infarction has been
limited by patient delay in seeking care. We sought to characterize prehospital delay in …

One of the major limitations to realizing the full potential of the life-saving effects of
thrombolytic therapy has been the failure to initiate treatment in the first 1 to 1.5 h after …